上市公司砍97%收入来源！三年亏17亿押注化学原料，能续命吗？

Core Viewpoint - The company is undergoing a drastic transformation by eliminating 97% of its revenue source, indicating a desperate attempt to survive as it faces potential delisting [1] Group 1: Financial Performance - Since 2022, the company has not reported a positive net profit, accumulating losses exceeding 1.7 billion yuan over three years [3] - The core business, which involves propane to propylene production, has been severely impacted by high propane prices and low propylene sales, leading to a decline in gross margin from 20% in 2020 to -12.18% in the first three quarters of 2025 [4] Group 2: Strategic Shift - The company plans to pivot to a new business model centered around a new three-board company specializing in trimellitic anhydride (TMA), which has previously faced challenges in its IPO attempts due to its high gross margins [6] - In 2024, the new company experienced a significant profit surge, with net profit jumping from less than 50 million yuan to 600 million yuan, and gross margin reaching 64.89% [7] Group 3: Market Dynamics - The spike in TMA prices from 15,000 yuan/ton to 53,000 yuan/ton was driven by the shutdown of 70,000 tons of production capacity by a major global player [7] - However, by the second quarter of 2025, TMA prices are expected to drop below 20,000 yuan, with domestic competitors increasing production capacity, indicating a potential supply-demand imbalance [9] Group 4: Challenges in Transition - The company has not demonstrated a sustainable technological advantage or cost efficiency, raising concerns that its high profits are not based on inherent capabilities but rather on favorable market conditions [11] - Transitioning from traditional petrochemicals to high-tech specialty chemicals presents significant management challenges, as the operational focus shifts from scale and cost control to research and development, quality stability, and customer retention [13][14] Group 5: Risks of the Strategy - The controlling shareholder has limited options, as the old business has no recovery potential, making this strategic shift a last resort to avoid delisting [16] - The asset restructuring, while appearing as a rebirth, is essentially a high-risk gamble in a critical situation, with the true test lying in the new business's ability to withstand market cycles and competition [18]